A recent study found antibodies associated with RA and SLE in hospital patients with severe COVID-19. Additionally, one third of long Covid patients included in the study were observed to have elevated levels of autoantibodies for months post initial-infection.
Read More »Researchers at the Mayo Clinic ran a retrospective, comparative, multi-center study to determine if specific RA phenotypes may be responsible for poor COVID-19 outcomes.
Read More »New evidence suggests that an autoimmune response to the SARS-CoV-2 virus is responsible for neurological disorders in some COVID-19 patients. A 2022 review by Dr. Daniela Latorre from the Institute of Microbiology in Zurich, Switzerland, explains the “current knowledge of immune responses occurring in Neuro-COVID patients” and the potential mechanisms for developing neurological complications alongside SARS-CoV-2 infection.
Read More »A new study investigated vaccine efficacy of a primary series and booster dose across multiple variants, including the BA.1 omicron variant, in SLE patients. This is one of the first studies on vaccine efficacy of a primary series and booster dose across multiple variants, including the BA.1 omicron variant, especially in an autoimmune disease patient cohort.
Read More »